Public Charity

THE OVARIAN CANCER RESEARCH FUND INC

THE OVARIAN CANCER RESEARCH FUND INC, of NEW YORK, NY, is a Public Charity tracked in Imperigo's IRS 990 database. The 2025 filing shows $19.5M in revenue, $17.3M in expenses, $42.6M in total assets. IRS filings disclose 183 grants awarded by this foundation, totaling roughly $61.1M.

EIN: 133806788 NEW YORK, NY Federated Giving Programs NTEE: T70 Latest filing: 2025
Total Revenue$19.5M
Total Expenses$17.3M
Total Assets$42.6M
Grants Given183
Grant Total$61.1M
Filing Years2020–2025

Mission

OVARIAN CANCER RESEARCH ALLIANCE (OCRA) IS COMMITTED TO PREVENTING, DEVELOPING BETTER TREATMENTS FOR AND ULTIMATELY CURING OVARIAN AND RELATED GYNECOLOGIC CANCERS THROUGH INNOVATIVE RESEARCH, RAISING AWARENESS AND ENSURING THE BEST CARE POSSIBLE THROUGH ADVOCACY AND SUPPORT FOR PATIENTS AND FAMILIES.

Where $100 goes at The Ovarian Cancer Research Fund Inc

How The Ovarian Cancer Research Fund Inc divides every $100 it spends, from its own Form 990 filings, averaged across 8 years.

$79 Programs the work itself
$10 Management running the organization
$11 Fundraising raising the next dollar

Inside the $79 for programs

$58
Ovarian cancer research alliance was founded in 1994 (as The Ovarian Cancer Research Fund, inc.) And is a full-spectrum organization funding medical research, advocating on behalf of patients…
74% of program spending · Reported in the filing: 20,890 cases of ovarian
$18
In 2025, ovarian cancer research alliance (ocra) provided comprehensive education, support, and navigation services to thousands of individuals affected by ovarian and gynecologic cancers
22% of program spending · Reported in the filing: 167 mentors; 3,530 participants; 2,100 participants
$3
Ovarian cancer research alliance is a powerful voice on capitol hill, in statehouses around the country and with federal agencies for everyone touched by gynecologic cancer
4% of program spending
Share on LinkedIn Share on Facebook
Add this to your website

Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.

Before you apply to The Ovarian Cancer Research Fund Inc

Often funds new orgs 42% of recent recipients were first-time grantees (2023–2025).

Who to contact, what to include, deadlines, typical grant size and geographic focus are available with membership.

Officers & Directors

DIRECTOR Andrew Feuerstein Esq
TREATMENT ACCESS & SCIENTIFIC EDUCATION Anne Mette Hertz Sr Dir
PRESIDENT & CEO Audra L Moran
FORMER CHIEF FINANCIAL OFFICER Bibi Ali
DIRECTOR THRU AUG 2025 Carmel J Cohen Md
DIRECTOR Caroline Hirsch

Officer compensation and complete director data available with membership.

Top Grant Purposes

Research & Policy
$60,122,963 155 grants
Education
$592,743 16 grants
General Support
$432,523 12 grants

Financial Trends

Year Revenue Expenses Assets
2025 $19.5M $17.3M $42.6M
2024 $10.0M $13.6M $38.1M
2023 $13.4M $13.8M $39.2M
2022 $16.4M $11.5M $37.7M
2020 $7.7M $8.4M $29.4M

Between 2020 and 2025, reported annual revenue grew from $7.7M to $19.5M (+153%), with total assets most recently reported at $42.6M.

Interactive year-over-year charts and full filing details available with membership.

Grant Geography

Grants from this foundation were reported to recipients in AL, AR, AZ, CA, CO, FL, and 4 other states.

ALARAZCACOFLGAILINKS

Full geographic grant map with state-by-state breakdown available with membership.

See the full picture for THE OVARIAN CANCER RESEARCH FUND INC

Complete financials, all 183 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 880,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports
7-day free trial Cancel any time